BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21156935)

  • 21. Induction of apoptosis by the c-Myc helix-loop-helix/leucine zipper domain in mouse 3T3-L1 fibroblasts.
    Kohlhuber F; Hermeking H; Graessmann A; Eick D
    J Biol Chem; 1995 Dec; 270(48):28797-805. PubMed ID: 7499403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc.
    Yang W; Shen J; Wu M; Arsura M; FitzGerald M; Suldan Z; Kim DW; Hofmann CS; Pianetti S; Romieu-Mourez R; Freedman LP; Sonenshein GE
    Oncogene; 2001 Mar; 20(14):1688-702. PubMed ID: 11313917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Omomyc, a potential Myc dominant negative, enhances Myc-induced apoptosis.
    Soucek L; Jucker R; Panacchia L; Ricordy R; Tatò F; Nasi S
    Cancer Res; 2002 Jun; 62(12):3507-10. PubMed ID: 12067996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points.
    Mateyak MK; Obaya AJ; Sedivy JM
    Mol Cell Biol; 1999 Jul; 19(7):4672-83. PubMed ID: 10373516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MYC-nick promotes cell migration by inducing fascin expression and Cdc42 activation.
    Anderson S; Poudel KR; Roh-Johnson M; Brabletz T; Yu M; Borenstein-Auerbach N; Grady WN; Bai J; Moens CB; Eisenman RN; Conacci-Sorrell M
    Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5481-90. PubMed ID: 27566402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. c-Myc is essential for hematopoietic stem cell differentiation and regulates Lin(-)Sca-1(+)c-Kit(-) cell generation through p21.
    Baena E; Ortiz M; Martínez-A C; de Alborán IM
    Exp Hematol; 2007 Sep; 35(9):1333-43. PubMed ID: 17637497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The non-enzymatic RAS effector RASSF7 inhibits oncogenic c-Myc function.
    Kumaraswamy A; Mamidi A; Desai P; Sivagnanam A; Perumalsamy LR; Ramakrishnan C; Gromiha M; Rajalingam K; Mahalingam S
    J Biol Chem; 2018 Oct; 293(40):15691-15705. PubMed ID: 30139745
    [No Abstract]   [Full Text] [Related]  

  • 28. The ups and downs of Myc biology.
    Soucek L; Evan GI
    Curr Opin Genet Dev; 2010 Feb; 20(1):91-5. PubMed ID: 19962879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Function of the c-Myc oncoprotein.
    Kato GJ; Dang CV
    FASEB J; 1992 Sep; 6(12):3065-72. PubMed ID: 1521738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity.
    Crouch DH; Fisher F; Clark W; Jayaraman PS; Goding CR; Gillespie DA
    Oncogene; 1993 Jul; 8(7):1849-55. PubMed ID: 8510929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myc and ChREBP transcription factors cooperatively regulate normal and neoplastic hepatocyte proliferation in mice.
    Wang H; Dolezal JM; Kulkarni S; Lu J; Mandel J; Jackson LE; Alencastro F; Duncan AW; Prochownik EV
    J Biol Chem; 2018 Sep; 293(38):14740-14757. PubMed ID: 30087120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.
    Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS
    Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site.
    Hann SR; Dixit M; Sears RC; Sealy L
    Genes Dev; 1994 Oct; 8(20):2441-52. PubMed ID: 7958908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer therapeutics: targeting the dark side of Myc.
    Ponzielli R; Katz S; Barsyte-Lovejoy D; Penn LZ
    Eur J Cancer; 2005 Nov; 41(16):2485-501. PubMed ID: 16243519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A genetic screen to identify genes that rescue the slow growth phenotype of c-myc null fibroblasts.
    Berns K; Hijmans EM; Koh E; Daley GQ; Bernards R
    Oncogene; 2000 Jul; 19(29):3330-4. PubMed ID: 10918589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of c-Myc expression suppresses insulin gene transcription by inhibiting NeuroD/BETA2-mediated transcriptional activation.
    Kaneto H; Sharma A; Suzuma K; Laybutt DR; Xu G; Bonner-Weir S; Weir GC
    J Biol Chem; 2002 Apr; 277(15):12998-3006. PubMed ID: 11799123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myc and Mad bHLHZ domains possess identical DNA-binding specificities but only partially overlapping functions in vivo.
    James L; Eisenman RN
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10429-34. PubMed ID: 12149476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Function and regulation of the transcription factors of the Myc/Max/Mad network.
    Lüscher B
    Gene; 2001 Oct; 277(1-2):1-14. PubMed ID: 11602341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
    Gupta K; Anand G; Yin X; Grove L; Prochownik EV
    Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myc and Max function as a nucleoprotein complex.
    Blackwood EM; Kretzner L; Eisenman RN
    Curr Opin Genet Dev; 1992 Apr; 2(2):227-35. PubMed ID: 1638116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.